Frontiers in Medicine (Jul 2022)

Bibliometric Analysis of Cathepsin B Research From 2011 to 2021

  • Xiaoli Yang,
  • Xiaoli Yang,
  • Hua Yin,
  • Hua Yin,
  • Deyu Zhang,
  • Lisi Peng,
  • Keliang Li,
  • Fang Cui,
  • Chuanchao Xia,
  • Zhaoshen Li,
  • Haojie Huang

DOI
https://doi.org/10.3389/fmed.2022.898455
Journal volume & issue
Vol. 9

Abstract

Read online

Cathepsin B (CTSB) is a lysosomal protease implicated in the progression of various diseases. A large number of CTSB-related studies have been conducted to date. However, there is no comprehensive bibliometric analysis on this subject. In our study, we performed quantitative analysis of CTSB-related publications retrieved from the Science Citation Index Expanded (SCIE) of the Web of Science Core Collection (reference period: 2011–2021). A total of 3,062 original articles and reviews were retrieved. The largest number of publications were from USA (n = 847, 27.66%). The research output of each country showed positive correlation with gross domestic product (GDP) (r = 0.9745, P < 0.0001). Active collaborations between countries/regions were also observed. Reinheckel T and Sloane BF were perhaps the most impactful researchers in the research landscape of CTSB. Plos ONE was the most prevalent (119/3,062, 3.89%) and cited journal (3,021 citations). Comprehensive analysis of the top citations, co-citations, and keywords was performed to acquire the theoretical basis and hotspots of CTSB-related research. The main topics included CTSB-related cancers and inflammatory diseases, CTSB-associated cell death pattern, and the applications of CTSB. These results provide comprehensive insights into the current status of global CTSB-related research especially in pancreas, which is worthy of continued follow-up by practitioners and clinicians in this field.

Keywords